Novo’s Ozempic linked to rare cases of serious eye disorder, EU regulator says – Reuters

Posted on Author Tim Hodges Comments Off on Novo’s Ozempic linked to rare cases of serious eye disorder, EU regulator says – Reuters
  1. Novo’s Ozempic linked to rare cases of serious eye disorder, EU regulator says  Reuters
  2. GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds  statnews.com
  3. Ozempic makes you twice as likely to develop this debilitating condition — what that really means for your risk  New York Post
  4. Weight loss drugs linked to higher risk of eye damage in diabetic patients  The Guardian
  5. GLP-1 RAs Linked to Doubled Risk for Macular Degeneration  Medscape